Maternal Serum Markers Predicting Preeclampsia At Early Gestations

CompletedOBSERVATIONAL
Enrollment

18,000

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2024

Conditions
Pre-eclampsiaPreterm Birth
Interventions
DIAGNOSTIC_TEST

Blood test of PE risk

A blood test is applied to women between 11weeks and 13 weeks+6 days of GA at the first visit to evaluate risk of developing PE

DIAGNOSTIC_TEST

Blood test of Preterm PE risk

A blood test is applied to women between 11 weeks and 13 weeks+6 days of GA at the first visit to evaluate risk of developing Preterm PE

Trial Locations (6)

Unknown

Shenzhen Maternity & Child Healthcare Hospital, Shenzhen

the Eighth Affiliated Hospital, Shenzhen

The Third Affiliated Hospital of Zhengzhou University, Zhengzhou

Hunan Provincial Maternal and Child Health Care Hospital, Changsha

Qilu Hospital of Shandong University, Jinan

Women's Hospital, of Zhejiang University School of Medicine, Hangzhou

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Shenzhen Maternity & Child Healthcare Hospital

OTHER

collaborator

Eighth Affiliated Hospital, Sun Yat-sen University

OTHER

collaborator

Women's Hospital, of Zhejiang University School of Medicine

UNKNOWN

collaborator

Third Affiliated Hospital of Zhengzhou University

OTHER

collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

Hunan Provincial Maternal and Child Health Care Hospital

OTHER

lead

HBI Solutions Inc.

INDUSTRY

NCT05131282 - Maternal Serum Markers Predicting Preeclampsia At Early Gestations | Biotech Hunter | Biotech Hunter